查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1978727

藥品合約包裝市場：依服務類型、自動化程度、材料類型、包裝類型、劑型及最終用戶分類－2026-2032年全球預測

Pharmaceutical Contract Packaging Market by Service Type, Automation Level, Material Type, Packaging Type, Dosage Form, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，藥品合約包裝市場價值將達到 353.7 億美元，到 2026 年將成長至 370 億美元，到 2032 年將達到 498.9 億美元，複合年成長率為 5.03%。

主要市場統計數據
基準年 2025 353.7億美元
預計年份：2026年 370億美元
預測年份 2032 498.9億美元
複合年成長率 (%) 5.03%

我們認為，合約包裝在實現我們整個藥品組合的產品完整性、合規性和商業性差異化方面發揮著日益重要的策略作用。

醫藥合約包裝產業在臨床供應連續性、品牌保護和法規遵循方面佔據著至關重要的地位。近年來，包裝已從一種商品化服務演變為產品完整性、病人安全和市場差異化的策略基礎。隨著製造商應對日益生物製藥、複雜的產品以及多元化的全球市場通路，包裝合作夥伴必須在各種材料和包裝規格方面提供精準性、可追溯性和柔軟性。

我們將探討自動化、數位化可追溯性、材料創新和不斷變化的終端用戶需求如何融合，從而重新定義合約包裝策略和能力。

在整個醫藥包裝產業，變革正在重塑競爭格局和營運重點。從全自動化生產線到半自動化單元，自動化技術的進步提高了生產效率，同時減少了人為錯誤並加強了污染控制。同時，數位化和序列化技術正在重新定義可追溯性，實現從填充到分銷的即時可視化，並支援更嚴格的防偽和供應鏈透明度監管要求。

本研究評估了到 2025 年關稅趨勢對包裝業務投入成本、籌資策略、合規負擔和資本配置的多方面影響。

到2025年，已宣布或實施的關稅措施的累積影響正為合約包裝業務帶來新的成本和策略複雜性。進口原料（例如玻璃、鋁、鋼和某些塑膠）關稅的提高推高了投入成本，迫使包裝企業重新評估其籌資策略和供應商關係。為此，許多企業加快了雙重採購的步伐，將採購轉向近岸供應商，並加強談判以確保利潤率，同時遵守受監管的材料規格。

基於全面細分的洞察揭示了自動化、最終用戶畫像、材料選擇、包裝、劑型和服務類型如何決定策略重點和營運設計。

細分市場分析揭示了整個合約包裝生態系統中價值和風險集中的區域，了解這些層面有助於企業領導者優先考慮投資和夥伴關係。對自動化程度的評估揭示了兩種截然不同的營運模式：人工包裝操作，在特定的小批量生產線和高度客製化的產品線中仍然發揮著至關重要的作用；以及自動化包裝操作，能夠實現規模化和一致性。在自動化領域，機器人系統為注射和易碎產品提供了最佳的重複性和無菌區優勢。另一方面，半自動化系統兼具柔軟性和成本優勢，適用於中等批量生產線和二次包裝作業。

區域差異化和生產能力優先排序：根據美洲、歐洲、中東和非洲以及亞太地區的法規環境和商業性現實，推動產能建設。

區域趨勢決定了投資和產能擴張在哪些方面能夠產生最大的策略價值，而採取區域差異化的方法對於確保業務營運的韌性至關重要。在美洲，一體化的供應鏈、大規模的生物製藥研發管線以及完善的法規結構，催生了對先進的無菌填充和包裝能力、序列化能力以及強大的二級和三級物流的需求。該地區也為近岸籌資策略提供了機遇，這些策略可以降低關稅風險，並支持對市場需求的快速反應。

策略聯盟、垂直整合、專業化以及透過投資品質系統和自動化來提高競爭力，正在推動滿足多樣化的藥品包裝需求。

主要企業的趨勢凸顯了整合、策略聯盟和能力專業這三大關鍵主題。合約包裝公司正在加強與材料供應商、設備供應商和技術公司的合作，以加快獲得先進的填充、貼標和序列化能力，同時降低資本密集度。這些合作也有助於快速部署已驗證的生物製藥和複雜劑型生產線。同時，一些公司正在尋求垂直整合，以獲取高收益服務，例如設計開發、序列化和追蹤管理。另一些公司則透過專注於無菌注射劑、低溫運輸能力和大批量泡殼包裝等細分領域來維持營運效率。

採取雙管齊下的務實方法，推動區域產能擴張和永續性舉措，同時最佳化落地成本，加快序列化進程，並規劃自動化投資。

產業領導者應採取雙管齊下的策略，兼顧短期韌性與長期能力建構。短期內，應優先最佳化到岸成本，具體措施包括重新設計供應商合約（例如納入關稅合規條款）、盡可能擴大雙重採購，以及實施針對I型玻璃替代品和高性能塑膠的材料再認證計劃（評估其穩定性等效性）。同時，應加快序列化和追蹤系統的實施，這些系統不僅要滿足監管要求，還要提供營運可視性，從而減少召回並提高退貨處理效率。

為了確保獲得切實有效的見解，我們採用了穩健的混合方法研究設計，結合了與行業相關人員的初步訪談、監管和技術審查、情景映射以及迭代專家檢驗。

本研究採用混合方法，結合了與關鍵相關人員的直接對話、二手技術審查和跨部門檢驗。主要資料收集包括對包裝經理、供應鏈主管、品質和法規專家以及設備供應商進行結構化訪談，以確定營運限制、驗證方法和新的投資重點。二手分析包括參考法規指南、關稅表和技術標準，以評估合規性對材料和工藝的影響。設備和材料規格為自動化和材料權衡提供了技術框架。

整合策略要求，強調採購彈性、模組化自動化、序列化和區域能力協調，以確保長期的營運和商業性優勢。

總之，合約包裝產業正處於轉折點，監管複雜性、關稅波動和技術進步等因素共同作用，重新定義了競爭優勢。那些能夠透過策略採購和落地成本建模積極應對投入成本波動、投資模組化自動化以提高品質和產能、並整合端到端序列化和追蹤系統的企業，將更有能力滿足生物製藥開發商、品牌所有者和學名藥生產商不斷變化的需求。此外，將產能部署與管理體制和客戶細分相匹配的區域策略，將有助於降低風險並創造成長機會。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：藥品合約包裝市場：依服務類型分類

  • 設計與開發
    • 概念設計
    • 原型
  • 灌裝/密封
    • 液體填充
    • 粉末填充
  • 標籤
    • 壓敏黏著劑
    • 濕黏合劑
  • 序列化和追蹤管理
    • 條碼
    • RFID標籤

第9章 醫藥合約包裝市場：依自動化程度分類

  • 自動包裝
    • 機器人系統
    • 半自動系統
  • 手工包裝

第10章：藥品合約包裝市場：依材料類型分類

  • 玻璃
  • 金屬
  • 塑膠

第11章 藥品合約包裝市場：依包裝類型分類

  • 初級包裝
    • 安瓿
    • 泡殼包裝
    • 管瓶
  • 二級包裝
    • 紙盒
    • 托盤
  • 三級包裝
    • 調色盤
    • 收縮膜

第12章：以劑型分類的藥品合約包裝市場

  • 液體
    • 注射藥物
    • 口服液體藥物
  • 半固態製劑
    • 奶油
    • 凝膠
    • 軟膏
  • 固態劑量
    • 膠囊
    • 藥片

第13章：藥品合約包裝市場：依最終用戶分類

  • 生技公司
    • 生物製藥開發公司
    • 生物相似藥生產商
  • 品牌擁有者
    • 跨國企業
    • 本地公司

第14章：醫藥合約包裝市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：藥品合約包裝市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 藥品合約包裝市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國藥品合約包裝市場

第18章：中國醫藥合約包裝市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Aenova Holding GmbH
  • Ajinomoto Bio-Pharma Services, Inc.
  • Almac Pharma Services Ltd
  • Catalent Pharma Solutions, LLC
  • CordenPharma International Corp.
  • MJS Packaging
  • Nelipak Corporation
  • Nipro Corporation
  • Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • PCI Pharma Services, Inc.
  • Pfizer Inc.
  • Recipharm AB
  • Reed-Lane, Inc.
  • Ropack Inc.
  • Sharp Packaging Services, Inc.
  • Siegried Holding AG
  • Vetter Pharma-Fertigung GmbH & Co. KG
Product Code: MRR-2A0283E25592

The Pharmaceutical Contract Packaging Market was valued at USD 35.37 billion in 2025 and is projected to grow to USD 37.00 billion in 2026, with a CAGR of 5.03%, reaching USD 49.89 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 35.37 billion
Estimated Year [2026] USD 37.00 billion
Forecast Year [2032] USD 49.89 billion
CAGR (%) 5.03%

Framing the evolving strategic role of contract packaging as a mission-critical enabler of product integrity, compliance, and commercial differentiation across pharmaceutical portfolios

The pharmaceutical contract packaging sector occupies a pivotal position at the intersection of clinical supply continuity, brand protection, and regulatory compliance. Recent years have seen packaging evolve from a commoditized service to a strategic enabler of product integrity, patient safety, and market differentiation. As manufacturers grapple with increasingly complex biologics, combination products, and diversified global routes to market, packaging partners must deliver precision, traceability, and flexibility across a widening array of materials and formats.

Consequently, organizations that lead in integrating technology, quality systems, and supply chain resilience will set new performance baselines. This introduction frames the regulatory, operational, and strategic context that shapes current decision-making for contract packagers, brand owners, generics and biotechs alike. It highlights the imperative to adopt modular capabilities that accommodate diverse dosage forms, advanced serialization requirements, and evolving expectations around sustainability without compromising speed to market or compliance.

Exploring how automation, digital traceability, material innovation, and changing end-user demands are converging to redefine contract packaging strategies and capabilities

Across the pharmaceutical packaging landscape, transformative shifts are remaking competitive dynamics and operational priorities. Advances in automation, from fully robotic lines to semi-automated cells, are enabling higher throughput while reducing human error and improving contamination control. At the same time, digitalization and serialization technologies are reshaping traceability capabilities, enabling real-time visibility from filling to distribution and supporting stricter regulatory expectations for anti-counterfeiting and supply chain transparency.

Parallel to technological change, end-user demands are fragmenting. Biopharma innovators and biosimilars manufacturers require specialized sterile handling and cold-chain-compatible packaging, multinational brand owners seek consistent global labeling and branding controls, and regional and local generics prioritize cost efficiency and speed. Material innovation is also influencing design choices: glass types and metal alloys are being balanced against high-performance plastics according to stability, regulatory tolerance, and sustainability targets. Finally, service models are shifting toward integrated offerings that bundle design and development, filling, labeling, and serialization to provide single-source accountability and faster product commercialization timelines.

Assessing the multifaceted consequences of tariff developments through 2025 on input costs, sourcing strategies, compliance burdens, and capital allocation for packaging operations

The cumulative impact of tariff measures announced or implemented through 2025 has created a new layer of cost and strategic complexity for contract packaging operations. Increased duties on imported raw materials such as glass, aluminum, steel and certain plastics have elevated input costs and compelled packaging organizations to reassess sourcing strategies and supplier relationships. In response, many organizations accelerated dual-sourcing initiatives, shifted procurement toward nearer-shore suppliers, and intensified negotiations to preserve margin while maintaining compliance with regulatory material specifications.

These tariff-driven pressures have also influenced investment priorities. Firms that face sustained input-cost volatility have accelerated automation and efficiency programs to reduce unit labor cost and improve yield. At the same time, the reconfiguration of supply chains to avoid tariff exposure has led to higher inventory buffers in some regions and the selective relocation of critical production steps. Compliance considerations, including duty classification and documentation under the Harmonized Tariff Schedule and evolving trade enforcement practices, have obligated contract packagers to tighten import/export controls and to incorporate tariff risk into commercial terms. Consequently, procurement teams and commercial negotiators are increasingly embedding tariff clauses and landed-cost modeling into supplier contracts, while regulatory and quality teams work in parallel to ensure material substitutions meet stability and pharmacopoeial requirements.

Comprehensive segmentation-driven insights revealing how automation, end-user profiles, material choices, packaging formats, dosage forms, and service types determine strategic priorities and operational design

Segmentation analysis illuminates where value and risk concentrate across the contract packaging ecosystem, and understanding these strata helps leaders prioritize investments and partnerships. Evaluating automation level reveals two distinct operational cohorts: manual packaging operations that remain critical for certain low-volume or highly customized product lines, and automated packaging that delivers scale and consistency. Within automation, robotic systems offer the highest repeatability and sterile-zone benefits for injectable and sensitive formats, while semi-automated systems provide a balance of flexibility and cost for medium-volume runs and secondary packaging tasks.

End-user segmentation demonstrates how customer requirements drive service design. Biotech companies-differentiated between biopharma innovators and biosimilars manufacturers-demand high-touch, sterile handling and often bespoke packaging development. Brand owners, split into multinational companies and regional companies, require consistent labeling, global regulatory harmonization and scalable secondary and tertiary packaging solutions. Generic companies, represented by local generics, emphasize cost efficiency and rapid turnarounds. Material-type segmentation further refines operational choices: glass options such as Type I, II and III glass determine chemical inertness and shelf-life expectations; metal substrates, including aluminum and steel, provide barrier and mechanical strength for certain formats; and plastics-from high density polyethylene to polyethylene terephthalate and polyvinyl chloride-offer trade-offs among cost, barrier properties and sustainability profiles. Packaging type segmentation distinguishes primary formats like ampoules, blister packs and vials from secondary formats such as cartons and trays and from tertiary solutions including pallets and shrink wrap, each demanding different handling, labeling and unitization processes. Dosage-form segmentation separates liquid dosage into injectables and oral solutions, semi-solid forms into creams, gels and ointments, and solid dosage into capsules and tablets, which in turn determine filling technology, contaminant control, and packaging material compatibility. Service-type segmentation encapsulates design and development activities-concept design and prototyping-alongside filling and sealing for liquid and powder, labeling approaches that range from pressure sensitive to wet glue, and serialization and track and trace capabilities that include barcoding and RFID tagging, all of which together form end-to-end service bundles that customers expect when outsourcing packaging.

Regional differentiation and capacity prioritization across the Americas, Europe Middle East & Africa, and Asia-Pacific to align capabilities with regulatory and commercial realities

Regional dynamics are shaping where investment and capacity expansion will deliver the greatest strategic value, and a differentiated regional approach is necessary for resilient operations. In the Americas, integrated supply chains, large biologics pipelines, and established regulatory frameworks create demand for advanced sterile fill-finish capabilities, serialization compliance and robust secondary and tertiary logistics. This region also presents opportunities for near-shore sourcing strategies that mitigate tariff exposure and support rapid response to market demand.

Across Europe, the Middle East & Africa, regulatory harmonization and dense cross-border trade require flexible labeling and multilingual documentation management alongside sustainable packaging solutions that meet stringent environmental mandates. Companies operating here must balance centralized volume consolidation with localized packaging adaptations. In the Asia-Pacific region, fast-growing contract development and manufacturing ecosystems, combined with varied regulatory environments and competitive material supply chains, make cost-effective automation, scalable secondary packaging and rapid format changeovers essential. Each region therefore demands tailored commercial propositions, local supplier networks, and compliance architectures that align with regional regulatory regimes, logistics constraints, and customer expectations.

Competitive dynamics driven by strategic partnerships, vertical integration, specialization, and investments in quality systems and automation to capture diverse pharmaceutical packaging demands

Key company behaviors indicate consolidation, strategic partnerships, and capability specialization as dominant themes. Contract packaging providers are increasingly forming alliances with material suppliers, equipment vendors and technology firms to accelerate access to advanced filling, labeling and serialization capabilities while controlling capital intensity. Such partnerships also enable more rapid deployment of validated lines for biologics and complex dosage forms. Meanwhile, some firms pursue vertical integration to capture higher-margin services such as design and development or serialization and track-and-trace, while others focus on niche specialization-sterile injectables, cold-chain handling, or high-volume blister operations-to preserve operational efficiency.

Market leaders distinguish themselves through repeatable quality systems, regulatory expertise and robust validation protocols that reduce time-to-market for customers. They invest in workforce training to operate and maintain robotic and semi-automated cells, and they implement advanced analytics to monitor process performance, yield, and compliance. Emerging competitors differentiate on speed and price, leveraging modular lines and flexible staffing models to win smaller or regional contracts. Overall, competitive advantage accrues to companies that combine technical depth with commercial agility and the ability to deliver integrated service suites across design, fill-finish, labeling, and serialization.

Actionable dual-track recommendations to optimize landed cost, accelerate serialization, and sequence automation investments while expanding regional capability footprints and sustainability initiatives

Industry leaders should pursue a dual-track strategy that balances near-term resilience with long-term capability building. In the near term, prioritize landed-cost optimization by redesigning supplier contracts to include tariff contingency clauses, increasing dual-sourcing where feasible, and conducting material requalification programs that evaluate Type I glass alternatives and high-performance plastics for stability equivalence. Concurrently, accelerate the roll-out of serialization and track-and-trace systems that not only meet regulatory mandates but also provide operational visibility to reduce recalls and streamline returns.

For longer-term competitiveness, invest in a phased automation roadmap that sequences robotic systems for sterile and high-precision tasks while deploying semi-automated solutions for secondary packaging to preserve flexibility. Integrate design and prototyping capabilities to shorten development cycles and partner with equipment vendors on validation-ready solutions to reduce qualification timelines. Strengthen regional footprints by aligning capabilities to local regulatory realities and customer segments, and embed sustainability targets into material selection and tertiary unitization strategies. Finally, build a commercial model that offers modular service bundles-design and development, filling and sealing, labeling, serialization and track-and-trace-to capture a broader share of customer spend while providing single-source accountability for speed and quality.

Robust mixed-methods research design integrating primary industry interviews, regulatory and technical review, scenario mapping, and iterative expert validation to ensure actionable and defensible insights

This research employed a mixed-methods approach combining primary stakeholder engagement with secondary technical review and cross-functional triangulation. Primary data collection included structured interviews with packaging operations leaders, supply chain executives, quality and regulatory experts, and equipment providers to surface operational constraints, validation practices and emerging investment priorities. Secondary analysis drew from regulatory guidance, tariff schedules, and technical standards to assess compliance implications for materials and processes, while equipment and materials specifications provided the technical framing for automation and material trade-offs.

Analytical methods included scenario mapping to evaluate tariff-induced supply chain reconfigurations, capability gap analysis to identify where investments in automation and serialization yield the greatest operational returns, and segmentation analysis to align service offerings with customer types, dosage forms and packaging formats. Findings were validated through iterative expert review and by reconciling operational anecdotes with documented regulatory and technical requirements to ensure robustness. This methodology supports actionable insights while maintaining transparency on assumptions and the limitations inherent in rapidly changing trade and regulatory environments.

Synthesis of strategic imperatives emphasizing sourcing resilience, modular automation, serialization, and regional capability alignment to secure long-term operational and commercial advantage

In conclusion, the contract packaging sector stands at an inflection point where regulatory complexity, tariff dynamics, and technological advancement collectively redefine competitive advantage. Organizations that proactively address input-cost volatility through strategic sourcing and landed-cost modeling, that invest in modular automation to improve quality and throughput, and that embed end-to-end serialization and track-and-trace will be best positioned to serve the evolving needs of biopharma innovators, brand owners and generics manufacturers. Moreover, a regionally nuanced strategy that aligns capability deployment with regulatory regimes and customer segmentation will mitigate risk and unlock growth opportunities.

The path forward requires a disciplined focus on validated processes, workforce capability, and strategic partnerships that accelerate access to critical technologies and materials. By translating these insights into prioritized investments and operational changes, contract packagers and their customers can strengthen resilience, accelerate commercialization timelines, and protect product integrity across diverse markets.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Pharmaceutical Contract Packaging Market, by Service Type

  • 8.1. Design & Development
    • 8.1.1. Concept Design
    • 8.1.2. Prototyping
  • 8.2. Filling & Sealing
    • 8.2.1. Liquid Filling
    • 8.2.2. Powder Filling
  • 8.3. Labeling
    • 8.3.1. Pressure Sensitive
    • 8.3.2. Wet Glue
  • 8.4. Serialization & Track & Trace
    • 8.4.1. Barcoding
    • 8.4.2. RFID Tagging

9. Pharmaceutical Contract Packaging Market, by Automation Level

  • 9.1. Automated Packaging
    • 9.1.1. Robotic Systems
    • 9.1.2. Semi Automated Systems
  • 9.2. Manual Packaging

10. Pharmaceutical Contract Packaging Market, by Material Type

  • 10.1. Glass
  • 10.2. Metal
  • 10.3. Plastic

11. Pharmaceutical Contract Packaging Market, by Packaging Type

  • 11.1. Primary
    • 11.1.1. Ampoules
    • 11.1.2. Blister Packs
    • 11.1.3. Vials
  • 11.2. Secondary
    • 11.2.1. Cartons
    • 11.2.2. Trays
  • 11.3. Tertiary
    • 11.3.1. Pallets
    • 11.3.2. Shrink Wrap

12. Pharmaceutical Contract Packaging Market, by Dosage Form

  • 12.1. Liquid Dosage
    • 12.1.1. Injectable
    • 12.1.2. Oral Solutions
  • 12.2. Semi Solid
    • 12.2.1. Creams
    • 12.2.2. Gels
    • 12.2.3. Ointments
  • 12.3. Solid Dosage
    • 12.3.1. Capsules
    • 12.3.2. Tablets

13. Pharmaceutical Contract Packaging Market, by End User

  • 13.1. Biotech Companies
    • 13.1.1. Biopharma Innovators
    • 13.1.2. Biosimilars Manufacturers
  • 13.2. Brand Owners
    • 13.2.1. Multinational Companies
    • 13.2.2. Regional Companies

14. Pharmaceutical Contract Packaging Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Pharmaceutical Contract Packaging Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Pharmaceutical Contract Packaging Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Pharmaceutical Contract Packaging Market

18. China Pharmaceutical Contract Packaging Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Aenova Holding GmbH
  • 19.6. Ajinomoto Bio-Pharma Services, Inc.
  • 19.7. Almac Pharma Services Ltd
  • 19.8. Catalent Pharma Solutions, LLC
  • 19.9. CordenPharma International Corp.
  • 19.10. MJS Packaging
  • 19.11. Nelipak Corporation
  • 19.12. Nipro Corporation
  • 19.13. Patheon Pharma Services by Thermo Fisher Scientific Inc.
  • 19.14. PCI Pharma Services, Inc.
  • 19.15. Pfizer Inc.
  • 19.16. Recipharm AB
  • 19.17. Reed-Lane, Inc.
  • 19.18. Ropack Inc.
  • 19.19. Sharp Packaging Services, Inc.
  • 19.20. Siegried Holding AG
  • 19.21. Vetter Pharma-Fertigung GmbH & Co. KG

LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CONCEPT DESIGN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CONCEPT DESIGN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CONCEPT DESIGN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PROTOTYPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PROTOTYPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PROTOTYPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID FILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID FILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID FILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POWDER FILLING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POWDER FILLING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY POWDER FILLING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRESSURE SENSITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRESSURE SENSITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRESSURE SENSITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY WET GLUE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY WET GLUE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY WET GLUE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BARCODING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BARCODING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BARCODING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY RFID TAGGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY RFID TAGGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY RFID TAGGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI AUTOMATED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MANUAL PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GLASS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PLASTIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AMPOULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BLISTER PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY VIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CARTONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TRAYS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PALLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SHRINK WRAP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY INJECTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY ORAL SOLUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CREAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY GELS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOPHARMA INNOVATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOSIMILARS MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MULTINATIONAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGIONAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 158. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 160. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 161. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 162. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 163. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 164. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 165. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 168. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2032 (USD MILLION)
  • TABLE 169. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2032 (USD MILLION)
  • TABLE 170. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 171. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 172. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2032 (USD MILLION)
  • TABLE 173. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 174. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 198. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 266. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PRIMARY, 2018-2032 (USD MILLION)
  • TABLE 268. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SECONDARY, 2018-2032 (USD MILLION)
  • TABLE 269. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY TERTIARY, 2018-2032 (USD MILLION)
  • TABLE 270. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DOSAGE FORM, 2018-2032 (USD MILLION)
  • TABLE 271. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LIQUID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 272. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SEMI SOLID, 2018-2032 (USD MILLION)
  • TABLE 273. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SOLID DOSAGE, 2018-2032 (USD MILLION)
  • TABLE 274. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BIOTECH COMPANIES, 2018-2032 (USD MILLION)
  • TABLE 276. MIDDLE EAST PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY BRAND OWNERS, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY DESIGN & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY FILLING & SEALING, 2018-2032 (USD MILLION)
  • TABLE 281. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY LABELING, 2018-2032 (USD MILLION)
  • TABLE 282. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY SERIALIZATION & TRACK & TRACE, 2018-2032 (USD MILLION)
  • TABLE 283. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATION LEVEL, 2018-2032 (USD MILLION)
  • TABLE 284. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY AUTOMATED PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 285. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 286. AFRICA PHARMACEUTICAL CONTRACT PACKAGING MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)

TABL